Phibro Animal Health Corporation (PAHC) Settles Into New 52-Week Low on March 08 Session

Equities Staff  |

Shares of Phibro Animal Health Corporation (PAHC) sank into a new 52-week low yesterday, and could be a company to watch at the open. The company’s stock fell to as low as $28.29 yesterday after opening at $28.55. By the closing bell, the company's stock was at $28.85 a share for a gain of 0.49%.

While no company wants to see their stocks fall into a new 52-week low, opportune investors may have reason to celebrate. Bullish investors with a healthy tolerance for risk may view this as a chance to buy stocks as distressed prices before a bounce back. With that said, whenever a stock falls into new negative territory, there usually is a compelling reason for it. Investors bearish on the stock might see the stock reaching its lowest price in a year as a sign of growing downward momentum and take it as a good reason to sell their shares. Bulls, though, could likely see a new 52-week low as the stock hitting its low point and anticipate a recovery in the share price.

Phibro Animal Health Corporation saw 65,487 shares of its stock trade hands, that's out of 40.45 million shares outstand. The stock has an average daily volume of n/a shares. After hitting a new 52-week low, Phibro Animal Health Corporation enters the new trading day with a market cap of 1.17 billion, a 50-day SMA of $n/a and a 200-day SMA of $n/a

Phibro Animal Health Corporation now has a P/E ratio of 16.3.

For a complete fundamental analysis analysis of Phibro Animal Health Corporation, check out Equities.com’s Stock Valuation Analysis report for PAHC.

Still paying commissions on stock trades? Equities.com now offers 100% commission free stock trading and flat-fee options trading for $89.95/month! Get started today by https://www.equities.com/trading

Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the US and other international countries.

Phibro Animal Health Corporation has 1,500 employees, is led by CEO Jack Clifford Bendheim, and makes its home in Teaneck, NJ.

Phibro Animal Health Corporation is also a component of the Russell 2000 Index, which is generally viewed as the most reliable indicator of the health of the broader small-cap market. Using a rules-based methodology, it creates a simple, unbiased view of how America's stable of smaller publicly traded companies are performing in the stock markets. The index consists of the 2,000 smallest companies of the 3,000 largest publicly-traded companies in the country as judged by market cap. It's constructed by Russell Investments, which also builds and maintains the Russell 3000 (an index consisting of all 3,000 biggest companies by market cap) and the large-cap Russell 1000 (which has the 1,000 largest companies from the Russell 3000).

To get more information on Phibro Animal Health Corporation and to follow the company’s latest updates, you can visit the company’s profile page here: PAHC’s Profile. For more news on the financial markets and emerging growth companies, be sure to visit Equities.com’s Newsdesk. Also, don’t forget to sign-up for our daily email newsletter to ensure you don’t miss out on any of our best stories.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.



DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Watchlist

Symbol Last Price Change % Change
AAPL

     
AMZN

     
HD

     
JPM

     
IBM

     

INTERVIEW: CEO Dr. Martin Eaton - Heads Up Checkup

Equities.com Host & Contributor Silvia Davi interviewing CEO of Heads Up Checkup, Dr. Martin Eaton.